MedTrace Logo

Prevention of Postoperative Nausea and Vomiting

NCT02382146 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-11-21

No results posted yet for this study

Summary

We designed this randomized, double- blind, single-center study to compare the efficacy of the combination of dexamethasone with ondansetron and dexamethasone with dimenhydrinate undergoing plastic surgery.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

dexamethasone ondansetron

dexamethasone 8 mg intravenous ondansetron 4 mg intravenous dimenhydrinate 1mg/kg intravenous

DRUG

Dexamethasone dimenhidrinate

dexamethasone 8 mg intravenous dimenhydrinate 1mg/kg intravenous

Sponsors & Collaborators

  • Yeditepe University Hospital

    lead OTHER

Principal Investigators

  • nurcan kızılcık · yeditepe UH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02382146 on ClinicalTrials.gov